Market Tracker

08/26 5:16pm ET

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

30.90
Delayed Data
As of Aug 26
 +0.53 / +1.75%
Today’s Change
19.59
Today|||52-Week Range
65.34
-50.10%
Year-to-Date
Better Buy: Amgen Inc. vs. Biogen
Aug 17 / MotleyFool.com - Paid Partner Content
Ionis Pharmaceuticals Inc Begins to Shift Focus
Aug 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close30.37
Today’s open30.23
Day’s range30.14 - 31.21
Volume1,873,671
Average volume (3 months)2,655,596
Market cap$3.7B
Dividend yield--
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)-44.49%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book18.20

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...+1.32+0.86%
ACADACADIA Pharmaceutica...+0.56+1.73%
PTHNPatheon NV-0.01-0.04%
AKRXAkorn Inc+0.13+0.49%
Data as of 4:01pm ET, 08/26/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.09
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts